Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
HIV and HCV Treatment, Shorter Antibiotic Courses, Malaria-Sniffing Dogs, and Other ID and HIV Reasons to Be Grateful, 2018 Edition
Just in time for Thanksgiving, Paul Sax, M.D., provides a rundown of developments that infectious disease and HIV specialists can be grateful for over the past year.
The assistant professor of medicine at Northwestern University discusses the challenges, and rewards, of being a gay man involved in HIV research.
Leading researchers and clinicians who influence best practices for conversations about the direct and indirect impact of HIV infection and treatment agree that communications regarding transmission must shift.
Three researchers talk about ongoing HIV cure research within the AIDS Clinical Trials Group, treatment interruptions, and when we might see a cure.
The noted HIV researcher reflects on recent advances, the search for a cure, and the long road ahead.
Sanjabi talks about her early interest in science, her innovative research toward an HIV cure, and the importance of mentoring early career investigators.
"Nationally, we've seen only modest progress in retaining people in HIV care. The amount of improvement hasn't been enough."
Should You Answer Medical Questions From Clinicians You Don't Know About Patients You've Never Seen?
"There are a few reasons _not_ to answer questions from clinicians you've never met about patients you haven't seen," writes Paul Sax, M.D.
"Since expression of gratitude makes you happier ... and whining does the reverse, I've decided to turn what was going to be a typical rant about dealing with insurance companies into an expression of thanks to a remarkable group of professionals."...